Alessandra Bosch: Swiss Delphi Consensus Study on Thrombophilia Testing Indications
Alessandra Bosch, Clinician Scientist at University of Zurich, Attending Physician (Senior Consultant) at Kinderspital Zürich, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Hämostaseologie, adding:
“Our Delphi consensus study on thrombophilia testing indications in Switzerland is now published in Hämostaseologie!
Considerable variation across international guidelines persists and despite their widespread use, thrombophilia testing practices remain heterogeneous.
We brought together 42 clinical experts from the Swiss Society of Haematology (SSH) and the Swiss Society of Pediatric Hematology and Oncology (SSPHO) to change that.
After two Delphi rounds, consensus was reached on 32 thrombophilia testing statements across key clinical scenarios: unprovoked and provoked VTE, unusual site thrombosis, hormone- and pregnancy-associated events, family history, and paediatric VTE.
I presented the findings yesterday at the SSH Diagnostic Meeting.
It was truly enriching to discuss these results directly with the haematologists and lab medicine specialists who face these decisions daily.
Thank you to all 42 survey participants and experts for your time and expertise, to my co-authors Cosima Suter, Lukas Graf, Sabine Ruosch Girsberger and the Working Party Haemostasis of the SSH for this great collaboration!”
Title: Current Indications for Thrombophilia Testing – A Modified Delphi Consensus Study in Switzerland
Authors: Alessandra Bosch, Cosima Suter, Lukas Graf, Sabine Ruosch-Girsberger
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 08:02Neda Ashayeri: Global Perspectives on Hemophilia and Rare Bleeding Disorders in Abu Dhabi
-
Oct 18, 2026, 07:55Anu Thomas: A Stepwise Laboratory Approach to Positive IAT and Pretransfusion Compatibility
-
Oct 18, 2026, 07:49Matthew Hazell: Molecular Matching and the Future of Transfusion Practice
-
Oct 18, 2026, 07:05Behnood Bikdeli: Vasculearn Network Highlights Expert Perspectives on PE Risk Stratification and Advanced Therapies
-
Oct 18, 2026, 06:27Gregory Makris: NEJM Study Supports Earlier Catheter-Directed Intervention in Intermediate-High–Risk PE
-
Oct 18, 2026, 06:26Danny Hsu: BLOOD 2026 Return to Aotearoa
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH